Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,948 | 403 | 90.8% |
| Travel and Lodging | $492.42 | 2 | 7.5% |
| Education | $110.37 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,585 | 131 | $0 (2024) |
| Janssen Biotech, Inc. | $784.97 | 51 | $0 (2024) |
| Boston Scientific Corporation | $513.53 | 3 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $488.85 | 31 | $0 (2022) |
| Celgene Corporation | $420.37 | 28 | $0 (2024) |
| PFIZER INC. | $248.25 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $210.89 | 20 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $177.28 | 13 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $169.53 | 14 | $0 (2017) |
| Allergan Inc. | $167.91 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $850.72 | 55 | ABBVIE INC. ($277.51) |
| 2023 | $620.40 | 34 | AbbVie Inc. ($183.94) |
| 2022 | $502.74 | 30 | Janssen Biotech, Inc. ($288.70) |
| 2021 | $511.56 | 36 | AbbVie Inc. ($291.55) |
| 2020 | $280.88 | 17 | AbbVie Inc. ($113.73) |
| 2019 | $1,254 | 58 | Boston Scientific Corporation ($513.53) |
| 2018 | $1,490 | 105 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($302.23) |
| 2017 | $1,041 | 73 | AbbVie, Inc. ($203.86) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Neuroscience | ||||||
| 08/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: VIROLOGY | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,085 | 1,135 | $1.1M | $118,233 |
| 2022 | 15 | 880 | 926 | $904,711 | $99,707 |
| 2021 | 16 | 892 | 938 | $874,783 | $103,948 |
| 2020 | 18 | 935 | 1,009 | $829,707 | $112,514 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 223 | 225 | $382,050 | $42,270 | 11.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 198 | 209 | $54,967 | $20,112 | 36.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 198 | 204 | $219,300 | $10,625 | 4.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 43 | 43 | $30,133 | $7,294 | 24.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 63 | 67 | $163,614 | $6,082 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 64 | 82 | $20,336 | $5,040 | 24.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 28 | $32,060 | $4,715 | 14.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 76 | $16,036 | $4,454 | 27.8% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 28 | 29 | $38,475 | $4,295 | 11.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 50 | $72,437 | $3,992 | 5.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $29,822 | $3,139 | 10.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 28 | 28 | $31,220 | $3,100 | 9.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $25,340 | $1,982 | 7.8% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 14 | 14 | $2,758 | $577.76 | 20.9% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 12 | 12 | $2,364 | $447.48 | 18.9% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 16 | 16 | $1,200 | $107.87 | 9.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 154 | 155 | $263,445 | $28,308 | 10.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 173 | 183 | $48,129 | $18,144 | 37.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 161 | 166 | $178,214 | $8,750 | 4.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 75 | $18,600 | $6,291 | 33.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 61 | 66 | $161,172 | $5,991 | 3.7% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 11 | 12 | $19,602 | $5,466 | 27.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 30 | 30 | $20,760 | $5,121 | 24.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $41,718 | $3,261 | 7.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $29,822 | $2,933 | 9.8% |
About Dr. Rubin Bahuva, M.D
Dr. Rubin Bahuva, M.D is a Internal Medicine healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326200536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rubin Bahuva, M.D has received a total of $6,551 in payments from pharmaceutical and medical device companies, with $850.72 received in 2024. These payments were reported across 408 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,948).
As a Medicare-enrolled provider, Bahuva has provided services to 3,792 Medicare beneficiaries, totaling 4,008 services with total Medicare billing of $434,402. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Evansville, IN
- Active Since 06/28/2008
- Last Updated 05/23/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326200536
Products in Payments
- STELARA (Biological) $608.39
- GENERAL POLYPECTOMY (Device) $513.53
- ZEPOSIA (Drug) $420.37
- XIFAXAN (Drug) $339.11
- Humira (Biological) $325.80
- HUMIRA (Biological) $293.92
- RINVOQ (Biological) $283.84
- SKYRIZI (Biological) $263.17
- XELJANZ (Drug) $248.25
- Entyvio (Biological) $166.50
- Trulance (Drug) $159.90
- REMICADE (Biological) $158.27
- VIBERZI (Drug) $131.01
- CAMZYOS (Drug) $128.03
- Movantik (Drug) $124.19
- ArmonAir Digihaler (Drug) $122.88
- XIFAXANIBSD (Drug) $120.91
- MAVYRET (Drug) $115.33
- LINZESS (Drug) $113.06
- DIFICID (Drug) $101.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evansville
Dr. Douglas Sheffer, Md, MD
Internal Medicine — Payments: $77,392
Dr. Narothama Reddy Aeddula, Md, MD
Internal Medicine — Payments: $75,760
Dr. Karl Sash, Md, MD
Internal Medicine — Payments: $63,464
Adeel Siddiqui, M.d, M.D
Internal Medicine — Payments: $21,524
Anthony Voelkel, Md, MD
Internal Medicine — Payments: $19,840
Dr. James Evanson, Md, MD
Internal Medicine — Payments: $17,125